Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Tarsons Products Ltd (TARSONS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543399 NSE: TARSONS Plastic Products | Small Cap | Tarsons Products Share Price
₹332.20 -3.20 (-0.95%)
As on 25-Sep'26 16:59
Tarsons Products Ltd (TARSONS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543399 NSE: TARSONS Plastic Products | Small Cap | Tarsons Products Share Price
₹332.20 -3.20 (-0.95%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹1,768 Cr.
Current Price
₹332.2
52-Week Low / High
₹164 / 374
TTM EPS
₹2.1
TTM Sales
₹441 Cr.
Book Value per Share
₹119
P/E Ratio
159.31
Higher than its 5-year historical median
Industry PE
37.1
Price to Book (P/B)
2.79
Lower than its 5-year historical median
Price to Sales (P/S)
4.00
Lower than its 5-year historical median
EV/EBITDA
14.55
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
2.26%
Underperforms industry median
Return on Capital Employed (ROCE)
4.52%
Underperforms industry median
Return on Assets (ROA)
1.26%
Operating Profit Margin
28.1%
Net Profit Margin
3.39%
Gross Profit Margin
28.3%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
5.97%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
6.1%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-51.9%
Asset Quality
Promoter Holding
47.30%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹623 Cr.
Equity
₹10.6 Cr.
Face Value
₹2
All Time Low / High
₹164.15 / 928.65
Check Before You Invest
Quality
Not GoodValuation
Somewhat UndervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Tarsons Products Ltd a good quality company?
Tarsons Products Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Tarsons Products Ltd performance compare with that of its Peers?
Revenue growth of Tarsons Products Ltd vs industry peers?
Tarsons Products Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Tarsons Products Ltd?
Promoters hold 47.30% of the Tarsons Products Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Tarsons Products Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -16.05% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Tarsons Products Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 31.6% | 27.4% | 37.2% | 35.3% | 19% | 10.2% | 8.6% | 5.5% | - |
| Value Creation Index ⓘ | NA | NA | 1.3 | 1.0 | 1.7 | 1.5 | 0.4 | -0.3 | -0.4 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 179 | 176 | 229 | 301 | 283 | 277 | 314 | 333 | 348 |
| Sales YoY Gr. | - | NA | NA | -1.6% | 30.1% | 31.4% | -5.8% | -2.1% | 13.3% | 6% | - |
| Adj EPS ⓘ | 0 | 0 | 7.5 | 7.4 | 13.2 | 18.4 | 14.4 | 8.9 | 6.8 | 2.9 | 3.7 |
| YoY Gr. | - | NA | NA | -1.2% | 77.9% | 39.5% | -21.8% | -38.4% | -23.2% | -57.8% | - |
| BVPS (₹) ⓘ | 0 | 0 | 26.6 | 37.3 | 48 | 92.1 | 107 | 116.6 | 122.6 | 127 | 127.1 |
| Adj Net Profit ⓘ | 0 | 0 | 38.3 | 39.4 | 67.3 | 98.1 | 76.7 | 47.3 | 36.3 | 15.3 | 20 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 51.3 | 64.2 | 68.2 | 83.5 | 75.6 | 105 | 110 | 112 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 1.3 | 0.6 | 0.5 | 0.3 | 1.5 | 2.4 | 2.1 | 2.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 7.8% | 5.5% | 6% | ||||
| Adj EPS ⓘ | NA | -26.3% | -41.6% | -57.8% | ||||
| BVPSⓘ | NA | 21.5% | 5.9% | 3.6% | ||||
| Share Price | - | - | -16.1% | 8.3% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 28.3 | 23.7 | 30.5 | 26.7 | 14.5 | 8 | 5.7 | 2.3 | 2.9 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 40.1 | 38.9 | 45.1 | 50.8 | 45.7 | 37.3 | 33.6 | 33.3 | 32.2 |
| Net Profit Mgn % ⓘ | 0 | 0 | 21.4 | 22.4 | 29.4 | 32.6 | 27.1 | 17.1 | 11.6 | 4.6 | 5.7 |
| Debt to Equity ⓘ | 0 | 0 | 0.5 | 0.2 | 0.1 | 0 | 0.2 | 0.4 | 0.4 | 0.4 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 371 | 343 | 372 | 543 | 706 | 617 | 484 | 106 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 172 | 127 | 127 | 187 | 218 | 192 | 181 | -9 |
Valuation of Tarsons Products - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'21 | Mar'22 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Sales | 229 | 301 | 296 | 392 | 423 |
| Operating Expenses ⓘ + | 126 | 148 | 197 | 282 | 305 |
| Operating Profit ⓘ | 103 | 153 | 100 | 111 | 118 |
| Operating Profit Margin (%) | 45.1% | 50.8% | 33.7% | 28.3% | 27.8% |
| Other Income ⓘ + | 6 | 8 | 11 | 16 | 25 |
| Interest ⓘ | 3 | 4 | 10 | 20 | 23 |
| Depreciation ⓘ | 14 | 22 | 40 | 62 | 97 |
| Profit Before Tax ⓘ | 92 | 135 | 61 | 45 | 22 |
| Tax ⓘ | 24 | 34 | 18 | 15 | 8 |
| Profit After Tax | 69 | 101 | 43 | 30 | 14 |
| PAT Margin (%) | 30.1% | 33.5% | 14.4% | 7.6% | 3.4% |
| Adjusted EPS (₹) | 13.5 | 18.9 | 8.0 | 5.6 | 2.7 |
| Dividend Payout Ratio (%) | 0% | 0% | 25% | 0% | 0% |
| PARTICULARS | Mar'21 | Mar'22 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 244 | 490 | 613 | 630 | 635 | ||||||
| Debt + | 26 | 10 | 204 | 274 | 297 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | ||||||
| Trade Payables | 6 | 13 | 15 | 16 | 20 | ||||||
| Others Liabilities ⓘ | 115 | 160 | 157 | 174 | 234 | ||||||
| Total Liabilities ⓘ | 392 | 673 | 988 | 1,094 | 1,186 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 120 | 189 | 336 | 536 | 733 | ||||||
| CWIP ⓘ | 22 | 32 | 267 | 233 | 159 | ||||||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventories | 47 | 82 | 129 | 126 | 130 | ||||||
| Trade Receivables | 47 | 65 | 78 | 80 | 85 | ||||||
| Cash Equivalents | 3 | 86 | 23 | 26 | 25 | ||||||
| Others Assets ⓘ | 152 | 219 | 156 | 94 | 54 | ||||||
| Total Assets ⓘ | 392 | 673 | 988 | 1,094 | 1,186 | ||||||
| PARTICULARS | Mar'21 | Mar'22 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 68 | 83 | 103 | 114 | 118 |
| Cash Flow From Investing Activity ⓘ + | -64 | -138 | -285 | -145 | -130 |
| Cash Flow From Financing Activity ⓘ + | -27 | 130 | 136 | 39 | 9 |
| Net Cash Flow ⓘ | -23 | 75 | -47 | 8 | -3 |
| PARTICULARS | Mar'21 | Mar'22 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 28.19 | 27.42 | 7.73 | 4.79 | 2.26 | |||||
| ROCE (%) | 34.25 | 35.28 | 10.27 | 7.04 | 4.52 | |||||
| Asset Turnover Ratio | 0.58 | 0.56 | 0.36 | 0.38 | 0.37 | |||||
| PAT to CFO Conversion(x) | 0.99 | 0.82 | 2.4 | 3.8 | 8.43 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 75 | 68.10 | 88.10 | 73.30 | 71.30 | |||||
| Inventory Days | 74.50 | 78.30 | 130 | 118.50 | 110.50 | |||||
| Payable Days | 35.50 | 54.90 | 61.30 | 42.80 | 47.30 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Tarsons Products Ltd FAQs
The current trading price of Tarsons Products on 25-Sep-2026 16:59 is ₹332.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Tarsons Products stood at ₹1,767.5 Cr
The latest P/E ratio of Tarsons Products as of 24-Sep-2026 is 89.43.
The latest P/B ratio of Tarsons Products as of 24-Sep-2026 is 2.61.
The 52-week high of Tarsons Products is ₹374.4 and the 52-week low is ₹164.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Tarsons Products is ₹348 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Tarsons Products Ltd is a below average quality company.
The key valuation ratios of Tarsons Products Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Tarsons Products Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Tarsons Products Ltd
Tarsons Products is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (CROs), Diagnostic companies and hospitals. It manufactures a range of quality labware products which helps advance scientific discovery and improve healthcare. The company’s product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors and others.
The company caters to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, diagnostic companies, and hospitals. Some of its end customers include customers such as Indian Institute of Chemical Technology, National Centre for Biological Sciences across academic institutes and research organizations; Dr Reddy's Laboratories, Enzene Biosciences across pharmaceutical sectors; Syngene International, Veeda Clinical Research across CROs; and Molbio Diagnostics, Agappe Diagnostic, Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors such as diagnostics. It distributes its products to these end customers on a pan-India basis through its authorised distributors. It has long-standing relationships with its end customers as well as distributors, which it has achieved by aligning its offerings with their business needs and through the support of an on-ground sales and marketing team.
Business area of the company
The company presently manufactures disposable plastic labware, centrifuge ware, cryo labware, liquid handling system and instruments.
Major events and milestones
- 1983: Incorporation of the Company with manufacturing of reusable plastic products.
- 1984: Commenced production of pipette tips.
- 1987: Commenced production of CFT.
- 2002: Pioneered the first fully robotic clean room plant for manufacturing of molecular biology consumables.
- 2009: Obtained ISO 9001:2015 certificate for manufacturing facility.
- 2012: Set up manufacturing facility expanding into production of fully automatic centrifuge tubes, and cryogenic vials in Dhulagarh.
- 2018: Obtained ISO 13485:2016/NS-EN ISO 13485:2016 certificate for manufacturing facility.
- 2018: Clear Vision Investment Holdings acquired 49% equity shareholding in the Company.
- 2019: Set up line for PCR products in Jalan Industrial Complex at Jangalpur.
- 2020: Received CE-IVD certification for products.
- 2019-2021: Acquired 5 acres land to develop a facility for increase in production in Panchla.
You have 39 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
